Catestatin, a chromogranin A-derived peptide, is sympathoinhibitory and attenuates sympathetic barosensitivity and the chemoreflex in rat CVLM

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 302, Issue 3, 2012, Pages

  Gaede, Andrea H ^a   Pilowsky, Paul M ^a  

^a MACQUARIE UNIVERSITY   (Australia)

Author keywords

Hypertension; Hypoxic chemoreflex; Neuropeptides; Neuropharmacology

Indexed keywords

CATESTATIN; URETHAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CARDIOVASCULAR RESPONSE; CAROTID ARTERY; CAUDAL VENTROLATERAL MEDULLA; CHEMORECEPTOR; CHEMORECEPTOR REFLEX; EXHALATION; HEART RATE; HOMEOSTASIS; HYPOXIA; INHALATION; MEDULLA OBLONGATA; NERVE CONDUCTION; NONHUMAN; PHRENIC NERVE; PRESSORECEPTOR; PRIORITY JOURNAL; RAT; RESPIRATION CONTROL; RESPIRATORY FUNCTION; SPLANCHNIC NERVE; SYMPATHETIC NERVE; VAGOTOMY;

ANIMALS; ANOXIA; BAROREFLEX; BLOOD PRESSURE; CHEMORECEPTOR CELLS; CHROMOGRANIN A; HEART RATE; MALE; MEDULLA OBLONGATA; MICROINJECTIONS; MODELS, ANIMAL; PEPTIDE FRAGMENTS; PHRENIC NERVE; RATS; RATS, SPRAGUE-DAWLEY; SYMPATHETIC NERVOUS SYSTEM; SYMPATHOLYTICS;

EID: 84856980005     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00409.2011     Document Type: Article

References (50)

1. Aardal S, Helle KB, Elsayed S, Reed RK, Serck-Hanssen G. Vasostatins, comprising the N-terminal domain of chromogranin A, suppress tension in isolated human blood vessel segments. J Neuroendocrinol 5: 405-412, 1993.
2. Abbott SB, Pilowsky PM. Galanin microinjection into rostral ventrolateral medulla of the rat is hypotensive and attenuates sympathetic chemoreflex. Am J Physiol Regul Integr Comp Physiol 296: R1019-R1026, 2009.
3. Aberger K, Chitravanshi VC, Sapru HN. Cardiovascular responses to microinjections of nicotine into the caudal ventrolateral medulla of the rat. Brain Res 892: 138-146, 2001.
4. Angelone T, Quintieri AM, Brar BK, Limchaiyawat PT, Tota B, Mahata SK, Cerra MC. The antihypertensive chromogranin A-derived peptide catestatin as a novel endocrine/paracrine modulator of cardiac function: Inotropic and lusitropic actions on the rat heart [Online]. Endocrinology 149: 4780, 2008.
5. Burke PGR, Li Q, Costin ML, McMullan S, Pilowsky PM, Goodchild AK. Somatostatin 2A receptor-expressing presympathetic neurons in the rostral ventrolateral medulla maintain blood pressure. Hypertension 52: 1127-1133, 2008.
6. Cravo SL, Morrison SF. The caudal ventrolateral medulla is a source of tonic sympathoinhibition. Brain Res 621: 133-136, 1993.
7. Dampney RA. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 74: 323-364, 1994.
8. Fung MM, Salem RM, Mehtani P, Thomas B, Lu CF, Perez B, Rao F, Stridsberg M, Ziegler MG, Mahata SK, O'Connor DT. Direct vasoactive effects of the chromogranin a (CHGA) peptide catestatin in humans in vivo. Clin Exp Hypertens 32: 278-287, 2010.
9. Gaede AH, Lung MS, Pilowsky PM. Catestatin attenuates the effects of intrathecal nicotine and isoproterenol. Brain Res 1305: 86-95, 2009.
10. Gaede AH, Pilowsky PM. Catestatin in rat RVLM is sympathoexcitatory, increases barosensitivity, and attenuates chemosensitivity and the somatosympathetic reflex. Am J Physiol Regul Integr Comp Physiol 299: R1538-R1545, 2010.
11. Gayen JR, Gu Y, O'Connor DT, Mahata SK. Global disturbances in autonomic function yield cardiovascular instability and hypertension in the chromogranin A null mouse. Endocrinology 150: 5027-5035, 2009.
12. Helle KB, Corti A, Metz-Boutigue MH, Tota B. The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties. Cell Mol Life Sci 64: 2863-2886, 2007.
13. Hodgson A, Minson J, Chalmers J, Pilowsky P. The use of microinjected colloidal gold and immunocytochemistry to localise pressor sites in the rostral medulla oblongata of the rat. Neurosci Lett 77: 125-130, 1987.
14. Kashihara K, McMullan S, Lonergan T, Goodchild AK, Pilowsky PM. Neuropeptide Y in the rostral ventrolateral medulla blocks somatosympathetic reflexes in anesthetized rats. Auton Neurosci Basic 142: 64-70, 2008.
15. Kennedy BP, Mahata SK, O'Connor DT, Ziegler MG. Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivo. Peptides 19: 1241-1248, 1998.
16. Koshiya N, Huangfu D, Guyenet PG. Ventrolateral medulla and sympathetic chemoreflex in the rat. Brain Res 609: 174-184, 1993.
17. Kubo T, Asari T, Yamaguchi H, Fukumori R. Baroreceptor activation causes release of acetylcholine in the rostral ventrolateral medulla of the rat. Clin Exp Hypertens 20: 245-257, 1998.
18. Machado BH, Bonagamba LGH, Dun SL, Kwok EH, Dun NJ. Pressor response to microinjection of orexin/hypocretin into rostral ventrolateral medulla of awake rats. Regul Pept 104: 75-81, 2002.
19. Mahapatra NR, O'Connor DT, Vaingankar SM, Hikim AP, Mahata M, Ray S, Staite E, Wu H, Gu Y, Dalton N, Kennedy BP, Ziegler MG, Ross J, Mahata SK. Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog. J Clin Invest 115: 1942-1952, 2005.
20. Mahata SK, Mahapatra NR, Mahata M, Wang TC, Kennedy BP, Ziegler MG, O'Connor DT. Catecholamine secretory vesicle stimulustranscription coupling in vivo. Demonstration by a novel transgenic promoter/photoprotein reporter and inhibition of secretion and transcription by the chromogranin A fragment catestatin. J Biol Chem 278: 32058-32067, 2003.
21. Mahata SK, Mahata M, Livsey Taylor CV, Taupenot L, Parmer RJ, O'Connor DT. The novel catecholamine release-inhibitory peptide catestatin (chromogranin A344-364). Properties and function. Adv Exp Med Biol 482: 263-277, 2000.
22. Mahata SK, Mahata M, Parmer RJ, O'Connor DT. Desensitization of catecholamine release. The novel catecholamine release-inhibitory peptide catestatin (chromogranin a344-364) acts at the receptor to prevent nicotinic cholinergic tolerance. J Biol Chem 274: 2920-2928, 1999.
23. Mahata SK, Mahata M, Wen G, Wong WB, Mahapatra NR, Hamilton BA, O'Connor DT. The catecholamine release-inhibitory "catestatin" fragment of chromogranin A: naturally occurring human variants with different potencies for multiple chromaffin cell nicotinic cholinergic responses. Mol Pharmacol 66: 1180-1191, 2004.
24. Mahata SK, O'Connor DT, Mahata M, Yoo SH, Taupenot L, Wu H, Gill BM, Parmer RJ. Novel autocrine feedback control of catecholamine release. A discrete chromogranin A fragment is a noncompetitive nicotinic cholinergic antagonist. J Clin Invest 100: 1623-1633, 1997.
25. Mandel DA, Schreihofer AM. Central respiratory modulation of barosensitive neurones in rat caudal ventrolateral medulla. J Physiol 572: 881-896, 2006.
26. Mazza R, Gattuso A, Mannarino C, Brar BK, Barbieri SF, Tota B, Mahata SK. Catestatin (chromogranin A344-364) is a novel cardiosuppressive agent: inhibition of isoproterenol and endothelin signaling in the frog heart. Am J Physiol Heart Circ Physiol 295: H113-H122, 2008.
27. McAllen RM, Habler HJ, Michaelis M, Peters O, Janig W. Monosynaptic excitation of preganglionic vasomotor neurons by subretrofacial neurons of the rostral ventrolateral medulla. Brain Res 634: 227-234, 1994.
28. Miyawaki T, Goodchild AK, Pilowsky PM. Activation of mu-opioid receptors in rat ventrolateral medulla selectively blocks baroreceptor reflexes while activation of delta opioid receptors blocks somato-sympathetic reflexes. Neuroscience 109: 133-144, 2002.
29. Miyawaki T, Goodchild AK, Pilowsky PM. Maintenance of sympathetic tone by a nickel chloride-sensitive mechanism in the rostral ventrolateral medulla of the adult rat. Neuroscience 116: 455-464, 2003.
30. Moraes DJA, Bonagamba LGH, Zoccal DB, Machado BH. Modulation of respiratory responses to chemoreflex activation by L-glutamate and ATP in the rostral ventrolateral medulla of awake rats. Am J Physiol Regul Integr Comp Physiol 300: R1476-R1486, 2011.
31. Natarajan M, Morrison SF. Sympathoexcitatory CVLM neurons mediate responses to caudal pressor area stimulation. Am J Physiol Regul Integr Comp Physiol 279: R364-R374, 2000.
32. O'Connor DT, Kailasam MT, Kennedy BP, Ziegler MG, Yanaihara N, Parmer RJ. Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension. J Hypertens 20: 1335-1345, 2002.
33. Oshima N, McMullan S, Goodchild AK, Pilowsky PM. A monosynaptic connection between baroinhibited neurons in the RVLM and IML in Sprague-Dawley rats. Brain Res 1089: 153-161, 2006.
34. Pilowsky P, Llewellyn-Smith IJ, Arnolda L, Minson J, Chalmers J. Intracellular recording from sympathetic preganglionic neurons in cat lumbar spinal cord. Brain Res 656: 319-328, 1994.
35. Pilowsky PM, Arnolda LF, Chalmers JP, Llewellyn-Smith IJ, Minson JB, Miyawaki T, Sun QJ. Respiratory inputs to central cardiovascular neurons. Ann NY Acad Sci 783: 64-70, 1996.
36. Pilowsky PM, Goodchild AK. Baroreceptor reflex pathways and neurotransmitters: 10 years on. J Hypertens 20: 1675-1688, 2002.
37. Pilowsky PM, Lung MS, Spirovski D, McMullan S. Differential regulation of the central neural cardiorespiratory system by metabotropic neurotransmitters. Philos Trans R Soc Lond B Biol Sci 364: 2537-2552, 2009.
38. Preece NE, Nguyen M, Mahata M, Mahata SK, Mahapatra NR, Tsigelny I, O'Connor DT. Conformational preferences and activities of peptides from the catecholamine release-inhibitory (catestatin) region of chromogranin A. Regul Pept 118: 75-87, 2004.
39. Salem RM, Cadman PE, Chen Y, Rao F, Wen G, Hamilton BA, Rana BK, Smith DW, Stridsberg M, Ward HJ, Mahata M, Mahata SK, Bowden DW, Hicks PJ, Freedman BI, Schork NJ, O'Connor DT. Chromogranin A polymorphisms are associated with hypertensive renal disease. J Am Soc Nephrol 19: 600-614, 2008.
40. Schreihofer AM, Guyenet PG. Baro-activated neurons with pulse-modulated activity in the rat caudal ventrolateral medulla express GAD67 mRNA. J Neurophysiol 89: 1265-1277, 2003.
41. Schreihofer AM, Guyenet PG. The baroreflex and beyond: Control of sympathetic vasomotor tone by gabaergic neurons in the ventrolateral medulla. Clin Exp Pharmacol Physiol 29: 514-521, 2002.
42. Schreihofer AM, Ito S, Sved AF. Brain stem control of arterial pressure in chronic arterial baroreceptor-denervated rats. Am J Physiol Regul Integr Comp Physiol 289: R1746-R1755, 2005.
43. Smani T, Zakharov SI, Csutora P, Leno E, Trepakova ES, Bolotina VM. A novel mechanism for the store-operated calcium influx pathway. Nat Cell Biol 6: 113-120, 2004.
44. Smith JC, Abdala APL, Koizumi H, Rybak IA, Paton JFR. Spatial and functional architecture of the mammalian brain stem respiratory network: A hierarchy of three oscillatory mechanisms. J Neurophysiol 98: 3370-3387, 2007.
45. Somogyi P, Hodgson AJ, DePotter RW, Fischer-Colbrie R, Schober M, Winkler H, Chubb IW. Chromogranin immunoreactivity in the central nervous system. Immunochemical characterisation, distribution and relationship to catecholamine and enkephalin pathways. Brain Res 320: 193-230, 1984.
46. Stornetta RL. Neurochemistry of bulbospinal presympathetic neurons of the medulla oblongata. J Chem Neuroanat 38: 222-230, 2009.
47. Sun QJ, Goodchild AK, Chalmers JP, Pilowsky PM. The pre-Botzinger complex and phase-spanning neurons in the adult rat. Brain Res 809: 204-213, 1998.
48. Sun QJ, Minson J, Llewellyn-Smith IJ, Arnolda L, Chalmers J, Pilowsky P. Botzinger neurons project towards bulbospinal neurons in the rostral ventrolateral medulla of the rat. J Comp Neurol 388: 23-31, 1997.
49. Tseng CJ, Appalsamy M, Robertson D, Mosqueda-Garcia R. Effects of nicotine on brain stem mechanisms of cardiovascular control. J Pharmacol Exp Ther 265: 1511-1518, 1993.
50. Zhang D, Shooshtarizadeh P, Laventie BJ, Colin DA, Chich JF, Vidic J, de Barry J, Chasserot-Golaz S, Delalande F, Van Dorsselaer A, Schneider F, Helle K, Aunis D, Prevost G, Metz-Boutigue MH. Two chromogranin A-derived peptides induce calcium entry in human neutrophils by calmodulin-regulated calcium independent phospholipase A2. PLos One 4: e4501, 2009.